Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Bionova Constructs New GMP Biologics Manufacturing Center
Bionova plans to construct a new stateoftheart biologics manufacturing facility The new GMP biologics manufacturing center is constructed with an area covering 36,000 sq ft This new biomanufacturing site will make use of singleuse technologies
Tonix Pharmaceuticals Plans to Build New R & D Centre
Tonix Pharmaceuticals Holding Corp builds a new RD centre for developing vaccines and proteinbased therapeutics The new facility will be located in Massachusetts
Merck to Invest US$118 million in New Gene Therapy Manufacturing Plant
Merck, with an investment of US$118 million 100 million plans to build a new gene therapy manufacturing capacity to double the size of the existing capacity The new manufacturing site will be located in Carlsbad, California, USA
Advanced Accelerator Applications Plans to Build Second US Manufacturing Site in Indianapolis
Advanced Accelerator Applications plans to build a new manufacturing facility for currently approved therapy and pipeline drug candidates in Indianapolis The expansion would be the second US manufacturing site for targeted radioLigand therapy
WACKER Announces Plans to Invest in Amsterdam Biotech Site
WACKER has recently announced investment plans for its production facilities of biologics, LMPs live microbial products and vaccines located at Amsterdam site, at a middoubledigit millioneuro amount
Marken Expands GMP Facility in Frankfurt
Marken has announced its plans to double the space of GMP facility by expanding in Frankfurt to meet the frozen room storage capabilities in anticipation of the COVID19 vaccine and storage needs
Nephron Pharmaceuticals Corporation Invests US$215m in New Projects in Lexington County
Nephron Pharmaceuticals Corporation has announced major investment plan in Lexington County, where it is headquartered, with an investment of US$215 million
SEKISUI Diagnostics Invests US$ 18.6 million in cGMP Microbial Capacity Expansion
Sekisui Diagnostics announced its plans to invest US$ 186 million 144 million in biopharma CDMO business to expand cGMP microbial capacity located at its existing site in Maidstone
SCA Pharma to Build a New Production Facility in Little Rock
SCA Pharma announced its plans to expand operations with the construction of a new production facility in Little Rock, with an investment of over US$10 million, which includes renovation of the existing facility and building a new facility
Emergent BioSolutions Invests US$75 million in New Manufacturing Unit
Emergent BioSolutions has announced US$75 million investment plan to expand viral vector and gene therapy capabilities in its facility at Canton, Massachusetts This investment is part of the companys bid to strengthen its Contract Development
